Thalidomide-NH-CBP/p300 ligand 2

Names

[ Name ]:
Thalidomide-NH-CBP/p300 ligand 2

Biological Activity

[Description]:

Thalidomide-NH-CBP/p300 ligand 2 (P-007) is a PROTAC-based CBP and p300 degrader (extracted from patent WO2020173440)[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> PROTAC >> PROTAC

Signaling Pathways >> Epigenetics >> Epigenetic Reader Domain

[References]

[1]. LIU JING, et al. CYCLIC-AMP RESPONSE ELEMENT BINDING PROTEIN (CBP) AND/OR ADENOVIRAL E1A BINDING PROTEIN OF 300 KDA (P300) DEGRADATION COMPOUNDS AND METHODS OF USE. Patent WO2020173440.

Chemical & Physical Properties

[ Molecular Formula ]:
C₄₈H₅₇F₂N₁₁O₆

[ Molecular Weight ]:
922.03

Safety Information

[ Hazard Codes ]:
Xi

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.